Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2012; 18(30): 4019-4027
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4019
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4019
Table 1 Patient characteristics with gallbladder cancer n (%)
| IGBC | NIGBC | |
| No. of patients (n = 19) | 9 | 10 |
| Polyposis lesions | 7 (77.8) | 5 (50) |
| Nonpolyposis lesions | 1 (11.1) | 5 (50) |
| Histopathological grade | ||
| G1 | 3 (33.3) | 1 (10) |
| G2 | 6 (66.7) | 3 (30) |
| G3 | 0 | 6 (60) |
| Lymphatic invasion | ||
| + | 2 (22.2) | 4 (40) |
| - | 7 (77.8) | 6 (60) |
| Vessel invasion | ||
| + | 1 (11.1) | 1 (10) |
| - | 8 (88.9) | 9 (90) |
| Perineural invasion | ||
| + | 1 (11.1) | 3 (30) |
| - | 8 (88.9) | 7 (70) |
| Stage | ||
| 0 | 1 (11.1) | 0 |
| IA | 4 (44.4) | 2 (20) |
| IB | 1 (11.1) | 1 (10) |
| IIA | 0 | 1 (10) |
| IIB | 2 (22.2) | 4 (40) |
| III | 0 | 1 (10) |
| IV | 1 (11.1) | 1 (10) |
Table 2 Patient characteristics: Demographic data, histopathological classification, tumor node metastasis staging
| Patient | Gender | Age (yr) | Incidental | TNM 6th edition | Cystic duct | Resection | Size (mm) | Grade | Lymphatic | Vessel | Perineural | 5-yr survival |
| 1 | M | 63 | No | pT2 N1 Mx | R0 | R0 | 10 (NP) | G3 | No | R0 | No | Alive, 15 mo |
| 2 | F | 82 | No | pT4 N2 M1 | R0 | R1 | 45 (NP) | G3 | Yes | Yes | Yes | Dead, 3 mo |
| 3 | F | 60 | No | pT3 N1 Mx | R1 | R1 | 60 (P) | G3 | No | No | Yes | Dead, 6 mo |
| 4 | F | 72 | No | pT3 N1 Mx | R0 | R1 | 32 (NP) | G3 | Yes | No | No | Dead, 8 mo |
| 5 | M | 76 | No | pT4 N1 Mx | R0 | R1 | 49 (NP) | G3 | Yes | No | Yes | Dead, 7 mo |
| 6 | M | 81 | No | pT3 N0 Mx | R0 | R1 | 44 (NP) | G3 | No | No | No | Dead, 9 mo |
| 7 | F | 77 | No | pT2 N0 Mx | R0 | R0 | 20 (P) | G2 | No | No | No | Dead, 24 mo |
| 8 | F | 45 | No | PT1a N0 Mx | R0 | R0 | 25 (P) | G1 | No | No | No | Alive, no recurrence at 5 yr |
| 9 | F | 81 | No | PT3 N1 Mx | R0 | R1 | 24 (P) | G2 | Yes | No | No | Dead, 28 mo |
| 10 | F | 66 | No | pT1b N0 Mx | R0 | R0 | 7 (P) | G2 | No | No | No | Alive, no recurrence at 5 yr |
| 11 | M | 69 | Yes | pT1b N0 Mx | R0 | R0 | 15 (NP) | G1 | No | No | No | Alive, 38 mo (disease recurrence) |
| 12 | M | 65 | Yes | PT1a Nx Mx | R0 | R0 | 18 (P) | G1 | No | No | No | Alive, no recurrence at 6 yr |
| 13 | F | 72 | Yes | pT2 N0 Mx | R0 | R0 | 10 (NP) | G2 | No | No | No | Alive, no recurrence at 5 yr |
| 14 | M | 55 | Yes | pT2 N0 M1 | R1 | R1 | 30 (P) | G2-3 | No | Yes | Yes | Dead, 8 mo |
| 15 | F | 78 | Yes | pT2 N1 Mx | R0 | R0 | 14 (P) | G2-3 | Yes | No | No | Dead, 26 mo |
| 16 | F | 57 | Yes | pT1b N0 Mx | R0 | R0 | 30 (P) | G2-3 | No | No | No | Alive, no recurrence at 5 yr |
| 17 | M | 71 | Yes | pT2 N1 Mx | R0 | R0 | 20 (P) | G2-3 | Yes | No | No | Dead, 23 mo |
| 18 | F | 61 | Yes | pTis Nx Mx | R0 | R0 | 12 (P) | G1 | No | No | No | Alive, no recurrence at 5 yr |
| 19 | M | 69 | Yes | pT1b N0 Mx | R0 | R0 | 5 (P) | G2 | No | No | No | Alive, no recurrence at 5 yr |
Table 3 Patient characteristics: Type of operation and survival data
| Patient | Gender | Age (yr) | Incidental | TNM 6th edition | Cystic duct | Resection | Surgery | 5-yr survival |
| 1 | M | 63 | No | pT2 N1 Mx | R0 | R0 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Alive, 15 mo |
| 2 | F | 82 | No | pT4 N2 M1 | R0 | R1 | Wedge res. (IVb + V) + lymphadenectomy (Istage) + CBD res. | Dead, 3 mo |
| 3 | F | 60 | No | pT3 N1 Mx | R1 | R1 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Dead, 6 mo |
| 4 | F | 72 | No | pT3 N1 Mx | R0 | R1 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Dead, 8 mo |
| 5 | M | 76 | No | pT4 N1 Mx | R0 | R1 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Dead, 7 mo |
| 6 | M | 81 | No | pT3 N0 Mx | R0 | R1 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Dead, 9 mo |
| 7 | F | 77 | No | pT2 N0 Mx | R0 | R0 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Dead, 24 mo |
| 8 | F | 45 | No | PT1a N0 Mx | R0 | R0 | Cholecystectomy, no further surgery | Alive, no recurrence at 5 yr |
| 9 | F | 81 | No | PT3 N1 Mx | R0 | R1 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Dead, 28 mo |
| 10 | F | 66 | No | pT1b N0 Mx | R0 | R0 | Wedge res. (IVb + V) + lymphadenectomy (Istage) | Alive, no recurrence at 5 yr |
| 11 | M | 69 | Yes | pT1b N0 Mx | R0 | R0 | LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS exc | Alive, 38 mo (disease recurrence) |
| 12 | M | 65 | Yes | PT1a Nx Mx | R0 | R0 | Cholecystectomy | Alive, no recurrence at 6 yr |
| 13 | F | 72 | Yes | pT2 N0 Mx | R0 | R0 | LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS exc | Alive, no recurrence at 5 yr |
| 14 | M | 55 | Yes | pT2 N0 M1 | R1 | R1 | LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + CBD and PS exc | Dead, 8 mo |
| 15 | F | 78 | Yes | pT2 N1 Mx | R0 | R0 | Cholecystectomy, refused further surgery | Dead, 26 mo |
| 16 | F | 57 | Yes | pT1b N0 Mx | R0 | R0 | LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS exc | Alive, no recurrence at 5 yr |
| 17 | M | 71 | Yes | pT2 N1 Mx | R0 | R0 | LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS exc | Dead, 23 mo |
| 18 | F | 61 | Yes | pTis Nx Mx | R0 | R0 | LC | Alive, no recurrence at 5 yr |
| 19 | M | 69 | Yes | pT1b N0 Mx | R0 | R0 | Cholecystectomy, refused further surgery | Alive, no recurrence at 5 yr |
Table 4 Residual disease in the lymph nodes after re-resection for each pT (%)
Table 5 Five-year survival according to both stage of gallbladder cancer and type of surgery (%)
Table 6 Metastasis at port-site and at subcostal laparotomy (%)
- Citation: Cavallaro A, Piccolo G, Panebianco V, Menzo EL, Berretta M, Zanghì A, Vita MD, Cappellani A. Incidental gallbladder cancer during laparoscopic cholecystectomy: Managing an unexpected finding. World J Gastroenterol 2012; 18(30): 4019-4027
- URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4019.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4019
